Canadian Rapid Treatment Center of Excellence Opens Second Location Providing Ketamine Treatment for Adults with Depression Post published:November 9, 2020 Post category:Press Release
Ehave’s Dashboard to Meet the Challenge of Electronic Health Records Security with BurstIQ Partnership Utilizing Blockchain Technology Post published:November 9, 2020 Post category:Press Release
Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University Post published:November 9, 2020 Post category:Press Release
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care Post published:November 9, 2020 Post category:Press Release
Psychedelic Bulletin: Psychedelics Decriminalised in OR and DC; Cybin and Entheon to Go Public Post published:November 6, 2020 Post category:Psychedelic Bulletin
Entheon to List on CSE on or about Nov 12th Under Symbol ENBI Post published:November 6, 2020 Post category:Press Release
Cybin (CYBN) to Go Public on NEO Exchange on or about Nov 10th Post published:November 5, 2020 Post category:News
Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement Post published:November 5, 2020 Post category:Press Release
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services Post published:November 5, 2020 Post category:Press Release
COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020 Post published:November 5, 2020 Post category:Press Release